Agenda

All programs are listed in Mountain Time (MT).

Wednesday, November 8, 2023

Child & Adolescent Psychiatry Academy

9:00 am – 6:15 pm

Check-In & Materials Pickup

— Bartolin Hall

12:00 pm – 1:00 pm

Lunch Industry Symposium†: Addressing Unresolved Symptoms of Major Depressive Disorder (MDD)

Sponsored by Otsuka America Pharmaceutical, Inc. (Medical Affairs)

— International Center

Rakesh Jain, MD, MPH

1:10 pm – 1:15 pm

Welcome Remarks

1:15 pm – 2:15 pm

Along for the Ride: Treatment Considerations for Childhood Psychiatric Disorders with Co-Occurring Anxiety

Jeffrey R. Strawn, MD

2:15 pm – 3:15 pm

The Full Picture: Managing Autism Spectrum Disorder and its Frequent Psychiatric Comorbidities

Robyn P. Thom, MD

3:15 pm – 3:30 pm

Networking Break

3:30 pm – 4:30 pm

An Unwelcome Guest: Managing Comorbid Insomnia in Pediatric Mood Disorders

Manpreet K. Singh, MD, MS

4:30 pm – 5:30 pm

Double Trouble: Diagnosis and Pharmacotherapy of ADHD and Juvenile Bipolar Disorder

Timothy E. Willens, MD

5:30 pm – 6:00 pm

Faculty Panel Q&A

6:15 pm – 7:15 pm

Industry Poster Reception†

Sponsored by Sumitomo (Sunovion)

— Broadmoor Estate House

Thursday, November 9, 2023

Pre-Conference Workshop: Psychedelics

6:15 am – 9:30 am

Check-In & Materials Pickup

— Bartolin Hall

7:15 am – 8:15 am

Breakfast Industry Symposium†

— International Center

8:25 am – 8:30 am

Welcome Remarks

— Broadmoor Hall

8:30 am – 9:30 am

Psychedelics and Neuroplasticity: The Good, The Bad, and The Promising

Stephen M. Stahl, MD, PhD, DSc (Hon.)

9:30 am – 9:45 am

Networking Break

9:45 am – 10:45 am

Unveiling the Therapeutic Potential: Evidence Supporting the Use of Psychedelics for PTSD, SUD, and Other Indications

Roger S. McIntyre, MD, FRCPC

10:45 am – 11:45 am

Psychedelic-Assisted Psychotherapy for the Treatment of Depression

Robin Carhart-Harris, PhD

11:45 am – 12:00 pm

Faculty Panel Q&A

12:15 pm - 1:15 pm

Lunch Industry Symposia†: Moving Forward: An Informed Approach to the Diagnosis and Treatment of Tardive Dyskinesia

Sponsored by Neurocrine

— International Center

Rakesh Jain, MD, MPH

Lunch Industry Symposia†: The Science of TAAR1: A Potential New Target in Psychiatric Disorders

Sponsored by Sumitomo Pharma America, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc.

— Colorado Hall

Rakesh Jain, MD and Craig Chepke, MD DFAPA

NEI Congress

9:30 am – 7:00 pm

Check-In & Materials Pickup

— Bartolin Hall

1:25 pm – 1:30 pm

Welcome Remarks

— Broadmoor Hall

1:30 pm – 2:30 pm

Brain Networks, Circuits and Neurotransmitters: A Roadmap to Better Outcomes

Vladimir Maletic, MD, MS

2:30 pm – 3:30 pm

BPI and BPII: Diagnosing and Treating Across the Spectrum

Roger S. McIntyre, MD, FRCPC and Manpreet K. Singh, MD, MS

3:30 pm – 4:45 pm

Exhibit Hall Open / Networking Break

4:45 pm – 5:45 pm

Can’t Shake This Feeling: Differential Diagnosis and Treatment of Movement Disorders Associated with Antipsychotic Use

Laxman B. Bahroo, DO, MS, FAAN

5:45 pm – 6:45 pm

Upstream with a Paddle: Regulating Dopamine Via Trace Amine, Acetylcholine, and Glycine Modulation

Stephen M. Stahl, MD, PhD, DSc (Hon.)

7:00 pm – 8:00 pm

Dinner Industry Symposium†: A first-line approach for the treatment of ADHD

Sponsored by Supernus

— International Center

Ann Childress, MD and Greg Mattingly, MD

Friday, November 10

7:00 am – 8:00 am

Breakfast Industry Symposium†

Sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck

— International Center

8:10 am – 8:15 am

Welcome Remarks

8:15 am – 9:15 am

Get to the Point: Utilizing Long-Acting Injectable Antipsychotics to Improve Adherence and Prevent Relapse

Jonathan M. Meyer, MD and Amber Hoberg, NP

9:15 am – 10:00 am

Neurology for Psychiatrists

Laxman B. Bahroo, DO, MS, FAAN

10:15 am – 11:00 am

Exhibit Hall Open / Networking Break

10:15 am – 11:00 am

Morning Industry Symposium†: Targeting Neuroplasticity in the Treatment of Depression: The Potential Role of Digital Tools

Sponsored by Otsuka America Pharmaceutical, Inc.

— Bartolin Hall

Margaret Emerson, DNP, APRN, PMHNP-BC and Madhukar H. Trivedi, MD

11:00 am – 12:00 pm

You Can Hurry Drugs: Rapid-Acting Antidepressants, Treatment Resistance, and Neuroplasticity

Andrew J. Cutler, MD and Roger S. McIntyre, MD, FRCPC

12:15 pm – 1:15 pm

Lunch Industry Symposia†: A Clinical Overview of an Adjunctive Treatment for Major Depressive Disorder in Adults

Sponsored by AbbVie

— International Center

Greg Mattingly, MD

Lunch Industry Symposia†: Post-Traumatic Stress Disorder (PTSD): Unmet Needs within a Prevalent Psychiatric Disorder

Sponsored by Otsuka America Pharmaceutical, Inc. (Medical Affairs)

— Colorado Hall

Rakesh Jain, MD, MPH and Craig Chepke, MD, FAPA

1:30 pm – 2:15 pm

Neuroactive Steroids for the Treatment of PPD and MDD

Andrew J. Cutler, MD and Roger S. McIntyre, MD, FRCPC

2:15 pm – 3:15 pm

There’s No Place Like Home: Addressing Agitation in Dementia

Leslie Citrome, MD, MPH

3:15 pm – 4:45 pm

Scientific Poster Reception / Exhibit Hall Open

— Bartolin Hall

3:30 pm – 4:15 pm

Afternoon Industry Symposium†: An Established Therapy for Treatment-resistant Depression (TRD) in Adults

Sponsored by Janssen

— Bartolin Hall

Craig Chepke, MD

4:45 pm – 5:45 pm

Lithium 101: Hit the Road Jack If You Don't Know About ENaC

Jonathan M. Meyer, MD

5:45 pm – 6:30 pm

No Rest for the Weary: An Update on the Diagnosis and Treatment of Hypersomnia Disorders

Karl Doghramji, MD

6:45 pm – 7:45 pm

Dinner Industry Symposium†: Forging a New Path: Targeting Muscarinic Receptor Circuits in Schizophrenia

Sponsored by Karuna Therapeutics

— International Center

Christoph Correll, MD

Saturday, November 11

7:00 am – 8:00 am

Breakfast Industry Symposium†: Clinical Perspectives on Bipolar I and Bipolar II Depression, and a Treatment Option Approved for Both

Sponsored by Intra-Cellular Therapies, Inc.

— International Center

Rakesh Jain, MD

8:10 am – 8:15 am

Welcome Remarks

8:15 am – 9:15 am

Arousing Discussion: Differentiating Stimulant Medications for ADHD

David W. Goodman, MD, FAPA

9:15 am – 10:00 am

An “Apple” A Day: Implementing Prescription Digital Therapeutics into Clinical Practice

Andrew J. Cutler, MD

10:00 am – 11:00 am

Exhibit Hall Open / Networking Break

10:15 am – 11:00 am

Morning Industry Symposium†: The role of glutamatergic and monoaminergic signaling in major depressive disorder

Sponsored by Axsome Therapeutics, Inc.

— Bartolin Hall

Rakesh Jain, MD, MPH

11:00 am – 12:00 pm

What Tune is 'Tonin Playing? Serotonin Receptors and Their Applications in Treating Psychiatric Disorders

Thomas L. Schwartz, MD

12:15 pm – 1:15 pm

Lunch Industry Symposia†

Sponsored by Alkermes

— International Center

1:30 pm – 2:30 pm

Ho Hum to Aha! Treating Anhedonia and Emotional Blunting

Vladimir Maletic, MD, MS and Roger S. McIntyre, MD, FRCPC

2:30 pm – 3:30 pm

The Other Meds: Nonstimulant Treatment Options for ADHD

David W. Goodman, MD, FAPA

3:30 pm – 4:30 pm

Exhibit Hall Open / Networking Break

3:45 pm – 4:30 pm

Afternoon Industry Symposium†: Beyond the Monoamine Hypothesis: a glutamatergic approach to treating major depressive disorder

Sponsored by Axsome Therapeutics, Inc.

— Bartolin Hall

Greg Mattingly, MD and Theresa Cerulli, MD

4:30 pm – 5:30 pm

Choose Your Own Adventure: Optimizing Antipsychotic Treatments for Schizophrenia

Leslie Citrome, MD, MPH

5:30 pm – 6:30 pm

What’s In a Name? Using “Antipsychotics” to Treat Mood Disorders

Joseph F. Goldberg, MD

6:45 pm – 7:45 pm

Dinner Industry Symposium†: Learn More About This Long-Acting Injectable Option for Schizophrenia Treatment in Adults

Sponsored by Alkermes

— International Center

Greg Mattingly, MD

Sunday, November 12

7:00 am – 8:00 am

Breakfast Industry Symposium†: Beyond Dopamine: Current Understanding of the Neurobiology of Cognitive and Negative Symptoms of Schizophrenia

Sponsored by Boehringer-Ingelheim

— International Center

Christoph Correll, MD

8:10 am – 8:15 am

Welcome Remarks

8:15 am – 9:15 am

Nothing Personal: Diagnosis and Treatment of Personality Disorders

Thomas L. Schwartz, MD

9:15 am – 10:15 am

Level Up! Using Plasma Levels, Pharmacokinetics, and Pharmacodynamics to Guide Antipsychotic Prescribing

Jonathan M. Meyer, MD

10:15 am – 10:30 am

Networking Break

10:30 am – 11:30 am

Count On It: Optimizing Treatment for OCD and Social Anxiety

Jeffrey R. Strawn, MD

11:30 am – 12:30 pm

Only the Lonely: The Impact of Loneliness on Mental Health

Roger S. McIntyre, MD, FRCPC

12:30 pm – 12:35 pm

Closing Remarks

12:45 pm – 1:45 pm

Lunch Industry Symposia†

Sponsored by Sage/Biogen

— International Center

The agenda is subject to change.

†The content of all industry–sponsored non–CME/CE events (industry symposia, disease state sessions, and poster sessions) and the views expressed therein are those of the presenting entity and not of NEI. Non–CME/CE events are not part of the scientific program and do not provide CME/CE credit. By attending (or opening) a non–CME/CE event, the attendee opts in to receive follow–up information from the commercial sponsor. Meals are provided by NEI.